Public disclosure of clinical trials in children

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue 10, 2002, Pages 707-716

  Clavenna, Antonio ^a   Pandolfini, Chiara ^a   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Child; Clinical trial; Comparative study; European Union; Literature review; Therapeutics

Indexed keywords

ASTHMA; CHILD HEALTH CARE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EMBASE; EUROPEAN UNION; HEALTH CARE QUALITY; HUMAN; LAW; MEDICAL ETHICS; MEDICAL LITERATURE; META ANALYSIS; OTITIS MEDIA; OUTCOMES RESEARCH; PATIENT INFORMATION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; UNITED STATES; VACCINATION;

EID: 0036810202     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80075-3     Document Type: Conference Paper

References (47)

1. Chalmers I. Unbiased, relevant, and reliable assessments in health care: Important progress during the past century, but plenty of scope for doing better. BMJ. 1998; 317:1167-1168.
2. Hoppu K. Patient recruitment - European perspective. Pediatrics. 1999;104(3 Pt 2): 623-626.
3. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320:79-82.
4. Jong GW, van den Anker JN, Choonara I. FDAMA's written request list: Medicines for children. Lancet. 2001;357:398.
5. European Commission. Better Medicines for Children: Proposed Regulatory Actions on Paediatric Medicinal Products. Consultation document. Brussels, Belgium: European Commission; 2002.
6. Bonati M, Choonara I, Hoppu K, et al. Closing the gap in drug therapy. Lancet. 1999;353:1625.
7. Impicciatore P, Pandolfini C, Bonati M. Database could give children safer medicines. Nature. 2000;405:882.
8. Maurer SM, Firestone RB, Scriver CR. Science's neglected legacy. Nature. 2000;405: 117-120.
9. Klassen TP, Wiebe N, Russell K, et al. Abstracts of randomized controlled trials presented at the Society for Pediatric Research meeting: An example of publication bias. Arch Pediatr Adolesc Med. 2002;156:474-479.
10. The metaRegister of Controlled Trials. Available at: http://www.controlled-trials.com/mrct. Accessed July 29, 2002.
11. Bonati M, Impicciatore P, Pandolfini C. Register of clinical trials in children must be set up. BMJ. 2000;320:1339-1340.
12. Smyth RL. Research with children. Paediatric practice needs better evidence - Gained in collaboration with parents and children. BMJ. 2001;322:1377-1378.
13. Meijer GG, Postma DS, Mulder PG, van Aalderen WM. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1887-1892.
14. Russell G, Williams DA, Weller P, Price JF. Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol. 1995;75:423-428.
15. Cracco G, Dal Negro R, Boer LA, et al. Salmeterol (50 mcg b.i.d.) versus nedocromil (4 mg t.i.d.): Protective effect against hyperreactivity to ultrasonically nebulised distilled water in asthmatic children. Riv Ital Pediatr. 1995;21:807-812.
16. Barbato A, Tormena F, Novello A, Cracco A. Effect of a month of treatment with inhaled steroids (flunisolide) on the bronchial responsiveness in children with moderate asthma. Riv Ital Pediatr. 1995;21:723-726.
17. Custovic A, Taggart SC, Stuart A, et al. Efficacy of a new non-ozone depleting formulation for salbutamol. J Pharmacol Med. 1995;5:161-168.
18. Dal Col G, Martinati L, Mingoni S, et al. Salbutamol powder, administered via a multidose and a single-dose powder inhaler, in the prevention of exercise-induced asthma in children. Pediatr Asthma Allergy Immunol. 1995:9:165-171.
19. Hoekstra MO, Grol MH, Bouman K, et al. Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1039-1044.
20. Marchisio P, Principi N, Sala E, et al. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. Antimicrob Agents Chemother. 1996;40:2732-2736.
21. Uhari M, Kontiokari T, Koskela M, Niemela M. Xylitol chewing gum in prevention of acute otitis media: Double blind randomised trial. BMJ. 1996;313:1180-1184.
22. Agertoft L, Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol. 1997;99(6 Pt 1):773-780.
23. Agertoft L, Pedersen S. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: A dose response study. Eur Respir J. 1997;10:1507-1512.
24. Vikre-Jorgensen J, Agertoft L, Pedersen S. Dose titration of nebulized budesonide in young children. Pediatr Pulmonol. 1997;23:270-277.
25. Yiallouros PK, Milner AD, Conway E, Honour JW. Adrenal function and high dose inhaled corticosteroids for asthma. Arch Dis Child. 1997;76:405-410.
26. Ceugniet F, Cauchefer F, Fragneaud C, Evano-Celli I. Prophylactic treatment of exercise-induced asthma in children: Salmeterol or sodium cromoglycate single dose before exercise? Ann Pediatr. 1997;44:625-634.
27. Cohen R, De la Rocque F, Boucherat M, et al. Randomized trial comparing 5-day cefpodoxime proxetil and 8-day amoxicillin-clavulanate treatment of acute otitis media in children. Med Mal Infect. 1997;27:596-602.
28. Kafetzis DA, Malaka-Zafiriou C, Bairamis T, et al. Comparison of the efficacy and tolerability of clarithromycin suspension and cefuroxime axetil suspension in the treatment of acute otitis media in paediatric patients. Clin Drug Invest. 1997;14:192-199.
29. Cohen R, Levy C, Boucherat M, et al. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr. 1998;133:634-639.
30. Moller C, Stromberg L, Oldaeus G, et al. Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma. Pediatr Pulmonol. 1999;28:337-343.
31. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: A dose comparison study. Am J Respir Crit Care Med. 1999;160:126-131.
32. Cohen R, Navel M, Grunberg J, et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18:403-409.
33. Ruohola A, Heikkinen T, Jero J, et al. Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through typanostomy tubes. J Pediatr. 1999;134:459-463.
34. Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide in asthmatic children exposed to relevant allergens: Effect of flunisolide. Eur Respir J. 2000;15:730-734.
35. Kuusela AL, Marenk M, Sandahl G, et al. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Pediatr Pulmonol. 2000;29:194-201.
36. Farmer IS, Middle M, Savic J, et al. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Respir Med. 2000;94: 57-63.
37. Bisgaard H, Nielsen KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med. 2000;162:187-190.
38. Van den Berg NJ, Ossip MS, Hederos CA, et al. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatr Pulmonol. 2000;30:97-105.
39. Cohen R, Levy C, Boucherat M, et al. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19:458-463.
40. Adler M, McDonald PJ, Trostmann U, et al. Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19(Suppl):S166-S170.
41. Ukkonen P, Varis K, Jernfors M, et al. Treatment of acute otitis media with an antiadhesive oligosaccharide: A randomised, double-blind, placebo-controlled trial. Lancet. 2000;356:1398-1402.
42. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, placebo-controlled study. Allergy. 2000;55:842-849.
43. Global Burden of Disease 2000 Version 1 Estimates. Available at: http://www3.who.int/whosis/menu.cfm?path=evidenc,burden,burden_gbd2000 &language=english. Accessed July 29, 2002.
44. Cochrane Child Health Field Web site. Available at: http://www.cochranechildhealth.org. Accessed July 29, 2002.
45. Cochrane Controlled Trials Register. Available at: http://www.update-software.com/cochrane. Accessed July 29, 2002.
46. Del Mar C, Glasziou P. A child with earache. Are antibiotics the best treatment? Aust Fam Phys. 2002;31:141-144.
47. Bauchner H, Sharfstein J. Failure to report ethical approval in child health research: Review of published papers. BMJ. 2001;323:318-319.